(INGR) Ingredion - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4571871023
Starches, Sweeteners, Corn Oil, Gluten Feed, Biomaterials
Dividends
| Dividend Yield | 2.96% |
| Yield on Cost 5y | 4.59% |
| Yield CAGR 5y | -1.82% |
| Payout Consistency | 96.0% |
| Payout Ratio | 28.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.3% |
| Value at Risk 5%th | 30.9% |
| Relative Tail Risk | -7.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.31 |
| Alpha | -27.81 |
| CAGR/Max DD | 0.23 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.440 |
| Beta | 0.305 |
| Beta Downside | 0.223 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.95% |
| Mean DD | 8.00% |
| Median DD | 5.76% |
Description: INGR Ingredion November 03, 2025
Ingredion Incorporated (NYSE: INGR) manufactures and markets a broad portfolio of corn-derived ingredients-including sweeteners, starches, nutrition ingredients, and biomaterial solutions-serving food & beverage, paper, textile, construction, pharmaceutical, cosmetics, and specialty industrial markets worldwide. Its product set spans everything from glucose syrups and high-fructose corn syrup to specialty starches for biodegradable plastics and water-filtration applications.
Key metrics and sector drivers: In fiscal 2023 the company generated roughly $6.5 billion in revenue with an adjusted EBITDA margin near 10 %, reflecting strong pricing power in high-growth “clean-label” and plant-based food segments. Ingredient demand is closely tied to corn commodity prices and global food-security trends, while end-market exposure to the expanding snack-and-convenience sector underpins volume growth. Additionally, Ingredion’s recent acquisitions in the specialty bioplastics space aim to capture a projected $45 billion market opportunity by 2030.
For a deeper quantitative view of INGR’s valuation and risk profile, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (659.0m TTM) > 0 and > 6% of Revenue (6% = 435.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -4.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.82% (prev 27.76%; Δ 3.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 975.0m > Net Income 659.0m (YES >=105%, WARN >=100%) |
| Net Debt (883.0m) to EBITDA (1.18b) ratio: 0.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (65.4m) change vs 12m ago -1.65% (target <= -2.0% for YES) |
| Gross Margin 25.43% (prev 23.07%; Δ 2.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.57% (prev 100.3%; Δ -5.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 25.84 (EBITDA TTM 1.18b / Interest Expense TTM 37.0m) >= 6 (WARN >= 3) |
Altman Z'' 6.34
| (A) 0.29 = (Total Current Assets 3.52b - Total Current Liabilities 1.28b) / Total Assets 7.83b |
| (B) 0.70 = Retained Earnings (Balance) 5.50b / Total Assets 7.83b |
| (C) 0.12 = EBIT TTM 956.0m / Avg Total Assets 7.68b |
| (D) 1.28 = Book Value of Equity 4.55b / Total Liabilities 3.57b |
| Total Rating: 6.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.42
| 1. Piotroski 6.50pt |
| 2. FCF Yield 10.80% |
| 3. FCF Margin 11.62% |
| 4. Debt/Equity 0.42 |
| 5. Debt/Ebitda 0.75 |
| 6. ROIC - WACC (= 5.82)% |
| 7. RoE 16.10% |
| 8. Rev. Trend -44.27% |
| 9. EPS Trend 64.58% |
What is the price of INGR shares?
As of December 12, 2025, the stock is trading at USD 111.20 with a total of 976,791 shares traded.
Over the past week, the price has changed by -0.16%, over one month by +1.22%, over three months by -13.08% and over the past year by -22.56%.
Over the past week, the price has changed by -0.16%, over one month by +1.22%, over three months by -13.08% and over the past year by -22.56%.
Is INGR a buy, sell or hold?
Ingredion has received a consensus analysts rating of 3.43.
Therefor, it is recommend to hold INGR.
- Strong Buy: 1
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the INGR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 124.3 | 11.8% |
| Analysts Target Price | 124.3 | 11.8% |
| ValueRay Target Price | 105.1 | -5.5% |
INGR Fundamental Data Overview December 03, 2025
Market Cap USD = 6.94b (6.94b USD * 1.0 USD.USD)
P/E Trailing = 10.7807
P/E Forward = 9.4607
P/S = 0.9556
P/B = 1.5903
P/EG = 1.126
Beta = 0.706
Revenue TTM = 7.26b USD
EBIT TTM = 956.0m USD
EBITDA TTM = 1.18b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 57.0m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 883.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.82b USD (6.94b + Debt 1.80b - CCE 921.0m)
Interest Coverage Ratio = 25.84 (Ebit TTM 956.0m / Interest Expense TTM 37.0m)
FCF Yield = 10.80% (FCF TTM 844.0m / Enterprise Value 7.82b)
FCF Margin = 11.62% (FCF TTM 844.0m / Revenue TTM 7.26b)
Net Margin = 9.07% (Net Income TTM 659.0m / Revenue TTM 7.26b)
Gross Margin = 25.43% ((Revenue TTM 7.26b - Cost of Revenue TTM 5.42b) / Revenue TTM)
Gross Margin QoQ = 25.06% (prev 26.02%)
Tobins Q-Ratio = 1.00 (Enterprise Value 7.82b / Total Assets 7.83b)
Interest Expense / Debt = 0.39% (Interest Expense 7.00m / Debt 1.80b)
Taxrate = 28.63% (69.0m / 241.0m)
NOPAT = 682.3m (EBIT 956.0m * (1 - 28.63%))
Current Ratio = 2.75 (Total Current Assets 3.52b / Total Current Liabilities 1.28b)
Debt / Equity = 0.42 (Debt 1.80b / totalStockholderEquity, last quarter 4.24b)
Debt / EBITDA = 0.75 (Net Debt 883.0m / EBITDA 1.18b)
Debt / FCF = 1.05 (Net Debt 883.0m / FCF TTM 844.0m)
Total Stockholder Equity = 4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.41% (Net Income 659.0m / Total Assets 7.83b)
RoE = 16.10% (Net Income TTM 659.0m / Total Stockholder Equity 4.09b)
RoCE = 16.39% (EBIT 956.0m / Capital Employed (Equity 4.09b + L.T.Debt 1.74b))
RoIC = 11.55% (NOPAT 682.3m / Invested Capital 5.91b)
WACC = 5.73% (E(6.94b)/V(8.74b) * Re(7.14%) + D(1.80b)/V(8.74b) * Rd(0.39%) * (1-Tc(0.29)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.76%
[DCF Debug] Terminal Value 74.55% ; FCFE base≈969.2m ; Y1≈774.5m ; Y5≈524.6m
Fair Price DCF = 153.4 (DCF Value 9.75b / Shares Outstanding 63.5m; 5y FCF grow -24.05% → 3.0% )
EPS Correlation: 64.58 | EPS CAGR: 27.99% | SUE: -0.80 | # QB: 0
Revenue Correlation: -44.27 | Revenue CAGR: 0.92% | SUE: -2.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.80 | Chg30d=-0.105 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=11.40 | Chg30d=-0.442 | Revisions Net=-6 | Growth EPS=+1.9% | Growth Revenue=+1.1%
P/E Trailing = 10.7807
P/E Forward = 9.4607
P/S = 0.9556
P/B = 1.5903
P/EG = 1.126
Beta = 0.706
Revenue TTM = 7.26b USD
EBIT TTM = 956.0m USD
EBITDA TTM = 1.18b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 57.0m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 883.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.82b USD (6.94b + Debt 1.80b - CCE 921.0m)
Interest Coverage Ratio = 25.84 (Ebit TTM 956.0m / Interest Expense TTM 37.0m)
FCF Yield = 10.80% (FCF TTM 844.0m / Enterprise Value 7.82b)
FCF Margin = 11.62% (FCF TTM 844.0m / Revenue TTM 7.26b)
Net Margin = 9.07% (Net Income TTM 659.0m / Revenue TTM 7.26b)
Gross Margin = 25.43% ((Revenue TTM 7.26b - Cost of Revenue TTM 5.42b) / Revenue TTM)
Gross Margin QoQ = 25.06% (prev 26.02%)
Tobins Q-Ratio = 1.00 (Enterprise Value 7.82b / Total Assets 7.83b)
Interest Expense / Debt = 0.39% (Interest Expense 7.00m / Debt 1.80b)
Taxrate = 28.63% (69.0m / 241.0m)
NOPAT = 682.3m (EBIT 956.0m * (1 - 28.63%))
Current Ratio = 2.75 (Total Current Assets 3.52b / Total Current Liabilities 1.28b)
Debt / Equity = 0.42 (Debt 1.80b / totalStockholderEquity, last quarter 4.24b)
Debt / EBITDA = 0.75 (Net Debt 883.0m / EBITDA 1.18b)
Debt / FCF = 1.05 (Net Debt 883.0m / FCF TTM 844.0m)
Total Stockholder Equity = 4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.41% (Net Income 659.0m / Total Assets 7.83b)
RoE = 16.10% (Net Income TTM 659.0m / Total Stockholder Equity 4.09b)
RoCE = 16.39% (EBIT 956.0m / Capital Employed (Equity 4.09b + L.T.Debt 1.74b))
RoIC = 11.55% (NOPAT 682.3m / Invested Capital 5.91b)
WACC = 5.73% (E(6.94b)/V(8.74b) * Re(7.14%) + D(1.80b)/V(8.74b) * Rd(0.39%) * (1-Tc(0.29)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.76%
[DCF Debug] Terminal Value 74.55% ; FCFE base≈969.2m ; Y1≈774.5m ; Y5≈524.6m
Fair Price DCF = 153.4 (DCF Value 9.75b / Shares Outstanding 63.5m; 5y FCF grow -24.05% → 3.0% )
EPS Correlation: 64.58 | EPS CAGR: 27.99% | SUE: -0.80 | # QB: 0
Revenue Correlation: -44.27 | Revenue CAGR: 0.92% | SUE: -2.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.80 | Chg30d=-0.105 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=11.40 | Chg30d=-0.442 | Revisions Net=-6 | Growth EPS=+1.9% | Growth Revenue=+1.1%
Additional Sources for INGR Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle